Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
Blood|February 24, 2019
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemiaDiego Sánchez-Martínez, Matteo L Baroni, Francisco Gutierrez-Agüera, et al.Blood|April 20, 2021
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemiaDanika Di Giacomo, Roberta La Starza, Paolo Gorello, et al.Leukemia|May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.Cancer Cell|June 5, 2003
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, Elizabeth H Stover, Christina L Boulton, et al.The New England Journal of Medicine|March 28, 2003
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeJan Cools, Daniel J DeAngelo, Jason Gotlib, et al.Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.Nature Genetics|December 25, 2012
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Zeynep Kalender Atak, Ning Li, et al.Cancer|November 28, 2018
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machineryGiorgia Simonetti, Antonella Padella, Italo Farìa do Valle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.Pageof 18